NASDAQ:OPK   Opko Health, Inc.
FDA approval on Jan 31st so this does have a time frame in which you can pull profits. They are partnered with pfizer on a drug that helps with HGH deficiency in human trials. Currently super low valuation and the fact that this drug will be in the public eye could make this pop. My expectations will be $6-7 for take profit but it could be more depending on the momentum. I would just try to purchase this within the two green boxes I have here on the chart.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.